Evidence map›Paper›PMID 37487500›Full record

ReviewJournal of medicinal chemistry2023

Principles and Applications of CF

Sebastian Vaas, Markus O Zimmermann, Dieter Schollmeyer, Jason Stahlecker, Marc U Engelhardt, Janosch Rheinganz, Bernhard Drotleff, Matthias Olfert, Michael Lämmerhofer, Markus Kramer and 2 more

Open access · greenAbstract readReview
In one paragraph

Review in Journal of medicinal chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
18.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. On the Nature of Improper Hydrogen Bonding in RCHAngewandte Chemie (International ed. in English) · 2026
    Article
  9. Construction of CFBeilstein journal of organic chemistry · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Ligand-to-Metal Charge Transfer of Ag(II) CFAngewandte Chemie (International ed. in English) · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Advances in the Study of Halogenated Natural Products.Current topics in medicinal chemistry · 2025
    Review
  20. Potent and Selective Human 5-HTJournal of medicinal chemistry · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Sebastian VaasLaboratory for Molecular Design & Pharmaceutical Biophysics, Institute of Pharmaceutical Sciences, Department of Pharmacy and Biochemistry, Eberhard Karls Universität Tübingen, 72076 Tübingen, Germany.
Markus O ZimmermannLaboratory for Molecular Design & Pharmaceutical Biophysics, Institute of Pharmaceutical Sciences, Department of Pharmacy and Biochemistry, Eberhard Karls Universität Tübingen, 72076 Tübingen, Germany.ORCID 0000-0001-6115-8248
Dieter SchollmeyerDepartment of Chemistry, Johannes Gutenberg-Universität Mainz, 55099 Mainz, Germany.
Jason StahleckerLaboratory for Molecular Design & Pharmaceutical Biophysics, Institute of Pharmaceutical Sciences, Department of Pharmacy and Biochemistry, Eberhard Karls Universität Tübingen, 72076 Tübingen, Germany.ORCID 0000-0002-0044-4037
Marc U EngelhardtLaboratory for Molecular Design & Pharmaceutical Biophysics, Institute of Pharmaceutical Sciences, Department of Pharmacy and Biochemistry, Eberhard Karls Universität Tübingen, 72076 Tübingen, Germany.ORCID 0009-0007-9152-8538
Janosch RheinganzLaboratory for Molecular Design & Pharmaceutical Biophysics, Institute of Pharmaceutical Sciences, Department of Pharmacy and Biochemistry, Eberhard Karls Universität Tübingen, 72076 Tübingen, Germany.
Bernhard DrotleffPharmaceutical (Bio)Analysis, Institute of Pharmaceutical Sciences, Department of Pharmacy and Biochemistry, Eberhard Karls Universität Tübingen, 72076 Tübingen, Germany.
Matthias OlfertPharmaceutical (Bio)Analysis, Institute of Pharmaceutical Sciences, Department of Pharmacy and Biochemistry, Eberhard Karls Universität Tübingen, 72076 Tübingen, Germany.
Michael LämmerhoferPharmaceutical (Bio)Analysis, Institute of Pharmaceutical Sciences, Department of Pharmacy and Biochemistry, Eberhard Karls Universität Tübingen, 72076 Tübingen, Germany.ORCID 0000-0002-1318-0974
Markus KramerInstitute of Organic Chemistry, Eberhard Karls Universität Tübingen, 72076 Tübingen, Germany.
Thilo StehleInterfaculty Institute of Biochemistry, Department of Pharmacy and Biochemistry, Eberhard Karls Universität Tübingen, 72076 Tübingen, Germany.
Frank M BoecklerLaboratory for Molecular Design & Pharmaceutical Biophysics, Institute of Pharmaceutical Sciences, Department of Pharmacy and Biochemistry, Eberhard Karls Universität Tübingen, 72076 Tübingen, Germany.ORCID 0000-0001-8738-6716
University of Tübingen · DEJohannes Gutenberg University Mainz · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As an orthogonal principle to the established (hetero)aryl halides, we herein highlight the usefulness of CF

Indexed as

Chemistry, PharmaceuticalHalogensBiologyDrug DiscoveryMolecular StructureHalogens

Identifiers

PMID37487500
PMCPMC10424184
OpenAlexW4385216105

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.